These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 14520864)
1. [Meloxicam: intramuscular administration in rheumatology]. Tsvetkova ES Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864 [No Abstract] [Full Text] [Related]
2. [Efficacy and intolerance of meloxicam in injection and tablet form]. Tiurin VP; Rakov AL Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079 [No Abstract] [Full Text] [Related]
3. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77]. Fenn GC; Morant SV Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122 [No Abstract] [Full Text] [Related]
4. Low-dose meloxicam (Vivlodex) for osteoarthritis pain. Med Lett Drugs Ther; 2016 Mar; 58(1490):35-6. PubMed ID: 26963155 [No Abstract] [Full Text] [Related]
5. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders. Patel BR J Indian Med Assoc; 2000 May; 98(5):250-2. PubMed ID: 11002624 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease. Degner F; Sigmund R; Zeidler H Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362 [TBL] [Abstract][Full Text] [Related]
7. [Meloxicam--the balance of efficacy and safety]. Morović-Vergles J Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285 [TBL] [Abstract][Full Text] [Related]
8. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521 [TBL] [Abstract][Full Text] [Related]
9. [Safety and efficacy of movalis injected into trigger points in lumbago-ischialgia syndrome]. Shirokov VA; Potaturko AV; Zakharov IaIu Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):41-4. PubMed ID: 18833170 [TBL] [Abstract][Full Text] [Related]
10. [The selective cox-2 inhibitor meloxicam and salicylate therapy]. Tóth K Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964 [TBL] [Abstract][Full Text] [Related]
11. [Cox-2 inhibitor i.m. in lumbago. This is not without risk!]. Koch HJ; Raschka C MMW Fortschr Med; 2003 Jan; 145(5):16. PubMed ID: 12619203 [No Abstract] [Full Text] [Related]
14. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis. Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638 [TBL] [Abstract][Full Text] [Related]
15. Meloxicam: new formulations and their use in rheumatology. Dequeker J; Degner F Inflamm Res; 2001 Mar; 50 Suppl 1():S3-4. PubMed ID: 11339518 [No Abstract] [Full Text] [Related]
16. A possible anaphylactoid reaction in a cow after intravenous meloxicam. Okushima S; Chesnel MA; Clutton RE Vet Anaesth Analg; 2013 May; 40(3):333-4. PubMed ID: 23438083 [No Abstract] [Full Text] [Related]
17. How beneficial is the use of NSAIDs in stem-cell transplantation? Hoggatt J; Pelus LM Expert Opin Pharmacother; 2013 Dec; 14(18):2453-6. PubMed ID: 24138174 [TBL] [Abstract][Full Text] [Related]
18. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients. Combe B; Vélicitat P; Garzón N; Bluhmki E Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515 [TBL] [Abstract][Full Text] [Related]